Molecular Psychiatry
Clairis N., Barakat A., Brochard J., Xin L., Sandi C.. A neurometabolic mechanism involving dmPFC/dACC lactate in physical effort-based decision-making - Molecular Psychiatry, 30: 899–913, 30 August 2024
Camporesi S., Xin L., Golay P., Eap C. B., Cleusix M., Cuenod M., Fournier M., Hashimoto K., Jenni R., Ramain J., Restellini R., Solida A., Conus P., Do K. Q., Khadimallah I.. Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study - Molecular Psychiatry, 29: 3669–3679, 07 June 2024
Merritt K, McCutcheon RA, Aleman A, Ashley S, Beck K, Block W, Bloemen OJN, Borgan F, Boules C, Bustillo JR, Capizzano AA, Coughlin JM, David A, de la Fuente-Sandoval C, Demjaha A, Dempster K, Do KQ, Du F, Falkai P, Galińska-Skok B, Gallinat J, Gasparovic C, Ginestet CE, Goto N, Graff-Guerrero A, Ho BC, Howes O, Jauhar S, Jeon P, Kato T, Kaufmann CA, Kegeles LS, Keshavan MS, Kim SY, King B, Kunugi H, Lauriello J, León-Ortiz P, Liemburg E, Mcilwain ME, Modinos G, Mouchlianitis E, Nakamura J, Nenadic I, Öngür D, Ota M, Palaniyappan L, Pantelis C, Patel T, Plitman E, Posporelis S, Purdon SE, Reichenbach JR, Renshaw PF, Reyes-Madrigal F, Russell BR, Sawa A, Schaefer M, Shungu DC, Smesny S, Stanley JA, Stone J, Szulc A, Taylor R, Thakkar KN, Théberge J, Tibbo PG, van Amelsvoort T, Walecki J, Williamson PC, Wood SJ, Xin L, Yamasue H, McGuire P, Egerton A. Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis - Molecular Psychiatry, : , January 2023
Khadimallah I, Jenni R, Cabungcal JH, Cleusix M, Fournier M, Klauser P, Knebel JF, Murray MM, Retsa C, Siciliano M, Spencer KM, Steullet P, Cuenod M, Conus P, Do KQ. Mitochondria, exosomes and gamma synchrony as biomarkers of parvalbumin interneurons and cognitive impairment in schizophrenia - Molecular Psychiatry, 27(2): 1192-1204, December 2022
Cherix A, Poitry-Yamate C, Lanz B, Zanoletti O, Grosse J, Sandi C, Gruetter R, Cardinaux JR. Deletion of Crtc1 leads to hippocampal neuroenergetic impairments associated with depressive-like behavior - Molecular Psychiatry, 27(11): 4485–4501, October 2022
Khadimallah I, Jenni R, Cabungcal JH, Cleusix M, Fournier M, Beard E, Klauser P, Knebel JF, Murray MM, Retsa C, Siciliano M, Spencer KM, Steullet P, Cuenod M, Conus P, Do KQ. Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia - Molecular Psychiatry, : , October 2021
Dwir D, Giangreco B, Xin L, Tenenbaum L, Cabungcal J, Steullet P, Goupil A, Cleusix M, Jenni R, Baumann PS, Klauser P, Conus P, Tirouvanziam R, Cuenod M, Do QK. MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients - Molecular Psychiatry, 25: 2889–2904, 2020
Maillard AM, Ruef A, Pizzagalli F, Migliavacca E, Hippolyte L, Adaszewski S, Dukart J, Ferrari C, Conus P, Männik K, Zazhytska M, Siffredi V, Maeder P, Kutalik Z, Kherif F, Hadjikhani N, Beckmann J, Reymond A, Draganski B, Jacquemont S. The 16p11.2 locus modulates brain structures common to autism, schizophrenia and obesity - Molecular Psychiatry, 20(1): 140-7, February 2015